KLHL2 interacts with and ubiquitinates WNK kinases

Biochemical and Biophysical Research Communications

Volumn 437, Issue 3, 2013, Pages 457-462

  Takahashi, Daiei ^a   Mori, Takayasu ^a   Wakabayashi, Mai ^a   Mori, Yutaro ^a   Susa, Koichiro ^a   Zeniya, Moko ^a   Sohara, Eisei ^a   Rai, Tatemitsu ^a   Sasaki, Sei ^a   Uchida, Shinichi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cullin 3; Kelch like protein 2; Ubiquitination; WNK kinase

Indexed keywords

CULLIN; DROSOPHILA PROTEIN; ISOPROTEIN; KLHL2 PROTEIN; PENTRAXIN; PROTEIN KINASE WNK1; PROTEIN KINASE WNK4; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DROSOPHILA; ENZYME ACTIVITY; FLUORESCENCE CORRELATION SPECTROSCOPY; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION;

EID: 84880944866     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.104     Document Type: Article

References (27)

1. Wilson F.H., Disse-Nicodème S., Choate K.A., Ishikawa K., Nelson-Williams C., Desitter I., Gunel M., Milford D.V., Lipkin G.W., Achard J.M., Feely M.P., Dussol B., Berland Y., Unwin R.J., Mayan H., Simon D.B., Farfel Z., Jeunemaitre X., Lifton R.P. Human hypertension caused by mutations in WNK kinases. Science 2001, 293:1107-1112.
2. Gordon R.D. The syndrome of hypertension and hyperkalemia with normal glomerular filtration rate: Gordon's syndrome. Aust. N.Z. J. Med. 1986, 16:183-184.
3. Richardson C., Alessi D.R. The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway. J. Cell Sci. 2008, 121:3293-3304.
4. Yang S.S., Morimoto T., Rai T., Chiga M., Sohara E., Ohno M., Uchida K., Lin S.H., Moriguchi T., Shibuya H., Kondo Y., Sasaki S., Uchida S. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab. 2007, 5:331-344.
5. Chiga M., Rai T., Yang S.S., Ohta A., Takizawa T., Sasaki S., Uchida S. Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone. Kidney Int. 2008, 74:1403-1409.
6. Ohta A., Rai T., Yui N., Chiga M., Yang S.S., Lin S.H., Sohara E., Sasaki S., Uchida S. Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure. Hum. Mol. Genet. 2009, 18:3978-3986.
7. Castañeda-Bueno M., Cervantes-Pérez L.G., Vázquez N., Uribe N., Kantesaria S., Morla L., Bobadilla N.A., Doucet A., Alessi D.R., Gamba G. Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process. Proc. Natl. Acad. Sci. USA 2012, 109:7929-7934.
8. Boyden L.M., Choi M., Choate K.A., Nelson-Williams C.J., Farhi A., Toka H.R., Tikhonova I.R., Bjornson R., Mane S.M., Colussi G., Lebel M., Gordon R.D., Semmekrot B.A., Poujol A., Välimäki M.J., De Ferrari M.E., Sanjad S.A., Gutkin M., Karet F.E., Tucci J.R., Stockigt J.R., Keppler-Noreuil K.M., Porter C.C., Anand S.K., Whiteford M.L., Davis I.D., Dewar S.B., Bettinelli A., Fadrowski J.J., Belsha C.W., Hunley T.E., Nelson R.D., Trachtman H., Cole T.R., Pinsk M., Bockenhauer D., Shenoy M., Vaidyanathan P., Foreman J.W., Rasoulpour M., Thameem F., Al-Shahrouri H.Z., Radhakrishnan J., Gharavi A.G., Goilav B., Lifton R.P. Mutations in kelch-like 3 and Cullin 3 cause hypertension and electrolyte abnormalities. Nature 2012, 482:98-102.
9. Louis-Dit-Picard H., Barc J., Trujillano D., Miserey-Lenkei S., Bouatia-Naji N., Pylypenko O., Beaurain G., Bonnefond A., Sand O., Simian C., Vidal-Petiot E., Soukaseum C., Mandet C., Broux F., Chabre O., Delahousse M., Esnault V., Fiquet B., Houillier P., Bagnis C.I., Koenig J., Konrad M., Landais P., Mourani C., Niaudet P., Probst V., Thauvin C., Unwin R.J., Soroka S.D., Ehret G., Ossowski S., Caulfield M., Bruneval P., Estivill X., Froguel P., Hadchouel J., Schott J.J., Jeunemaitre X., I.C.f.B.P.(ICBP) KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat. Genet. 2012, 44:456-460. S451-S453.
10. Furukawa M., Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell. Biol. 2005, 25:162-171.
11. Lee Y.R., Yuan W.C., Ho H.C., Chen C.H., Shih H.M., Chen R.H. The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to control interferon responses. EMBO J. 2010, 29:1748-1761.
12. Lin M.Y., Lin Y.M., Kao T.C., Chuang H.H., Chen R.H. PDZ-RhoGEF ubiquitination by Cullin3-KLHL20 controls neurotrophin-induced neurite outgrowth. J. Cell Biol. 2011, 193:985-994.
13. Wakabayashi M., Mori T., Isobe K., Sohara E., Susa K., Araki Y., Chiga M., Kikuchi E., Nomura N., Mori Y., Matsuo H., Murata T., Nomura S., Asano T., Kawaguchi H., Nonoyama S., Rai T., Sasaki S., Uchida S. Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension. Cell Rep. 2013, 3:858-868.
14. Shibata S., Zhang J., Puthumana J., Stone K.L., Lifton R.P. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4. Proc. Natl. Acad. Sci. USA 2013, 7838-7843.
15. Wu G., Peng J.B. Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation. FEBS Lett. 2013, 1717-1722.
16. Ohta A., Schumacher F.R., Mehellou Y., Johnson C., Knebel A., Macartney T.J., Wood N.T., Alessi D.R., Kurz T. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction. Biochem. J. 2013, 451:111-122.
17. Soltysik-Espanola M., Rogers R.A., Jiang S., Kim T.A., Gaedigk R., White R.A., Avraham H., Avraham S. Characterization of Mayven, a novel actin-binding protein predominantly expressed in brain. Mol. Biol. Cell 1999, 10:2361-2375.
18. Tseng L.A., Bixby J.L. Interaction of an intracellular pentraxin with a BTB-Kelch protein is associated with ubiquitylation, aggregation and neuronal apoptosis. Mol. Cell. Neurosci. 2011, 47:254-264.
19. Yamauchi K., Rai T., Kobayashi K., Sohara E., Suzuki T., Itoh T., Suda S., Hayama A., Sasaki S., Uchida S. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc. Natl. Acad. Sci. USA 2004, 101:4690-4694.
20. Ohta A., Yang S.S., Rai T., Chiga M., Sasaki S., Uchida S. Overexpression of human WNK1 increases paracellular chloride permeability and phosphorylation of claudin-4 in MDCKII cells. Biochem. Biophys. Res. Commun. 2006, 349:804-808.
21. Kuroki K., Kobayashi S., Shiroishi M., Kajikawa M., Okamoto N., Kohda D., Maenaka K. Detection of weak ligand interactions of leukocyte Ig-like receptor B1 by fluorescence correlation spectroscopy. J. Immunol. Methods 2007, 320:172-176.
22. Montague P., Kennedy P.G., Barnett S.C. Subcellular localization of Mayven following expression of wild type and mutant EGFP tagged cDNAs. BMC Neurosci. 2010, 11:63.
23. Jiang S., Avraham H.K., Park S.Y., Kim T.A., Bu X., Seng S., Avraham S. Process elongation of oligodendrocytes is promoted by the Kelch-related actin-binding protein Mayven. J. Neurochem. 2005, 92:1191-1203.
24. Bu X., Avraham H.K., Li X., Lim B., Jiang S., Fu Y., Pestell R.G., Avraham S. Mayven induces c-Jun expression and cyclin D1 activation in breast cancer cells. Oncogene 2005, 24:2398-2409.
25. Angers S., Thorpe C.J., Biechele T.L., Goldenberg S.J., Zheng N., MacCoss M.J., Moon R.T. The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation. Nat. Cell Biol. 2006, 8:348-357.
26. Prag S., Adams J.C. Molecular phylogeny of the kelch-repeat superfamily reveals an expansion of BTB/kelch proteins in animals. BMC Bioinformatics 2003, 4:42.
27. Lo S.C., Li X., Henzl M.T., Beamer L.J., Hannink M. Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. EMBO J. 2006, 25:3605-3617.